Complix
is a biopharmaceutical firm that focuses on the discovery and development of alphabody-based therapeutics and treatment of autoimmune diseases... Read moreComplix
is a biopharmaceutical firm that focuses on the discovery and development of alphabody-based therapeutics and treatment of autoimmune diseases... Read more
News
Jul 28, 2021
Markets Insider
Complix: Complix Signs Global Drug Discovery and Development Agreement with Jiangsu Nhwa Pharmaceutical Co. to Develop Novel Alphabody Therapeutics for Treatment of CNS Diseases
Mar 31, 2021
StreetInsider
Press Release: Complix : Complix and VIB Publish Pioneering Study on Cell-Penetrating Alphabodies in Science Advances
Mar 11, 2021
Pharmafile
Complix: Complix and I-Mab sign deal to develop alphabody cancer therapies
Mar 10, 2021
Seeking Alpha
Complix: I-MAB BioPharma And Its Dual Drug Portfolio
Oct 07, 2020
PharmiWeb
Complix: Complix receives 1.2 million VLAIO grant to develop a novel and differentiated class of anti-Covid-19 Alphabody therapeutics
Oct 12, 2018
BioPortfolio
Complix: Complix NV Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13082018 Prices from USD $250
Aug 16, 2018
BioPortfolio
Complix: Complix NV Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13042018 Prices from USD $250
May 11, 2018
BioPortfolio
Complix: Complix NV Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 27022018 Prices from USD $250
Feb 26, 2018
Industry Today
Press Release: Complix : Induced Myeloid Leukemia - Pipeline Review by Bcl 2 Related Protein EAT/Mcl1 or BCL2L3 or MCL1
Dec 14, 2017
FinSMEs
Complix: Complix Receives €0.5M Grant
Complix Competitors
1
2
3
4
5
6
7
8
9
10